BioLineRx Ltd. (BLRX)
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
Address
2 HAMA-AYAN STREET
MODI-IN, L3 7177871
Founded
2003
Number of Employees
38
Website
http://www.biolinerx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)